Home/Filings/4/0000899243-20-003578
4//SEC Filing

Hartzell Amy 4

Accession 0000899243-20-003578

CIK 0001364099other

Filed

Feb 6, 7:00 PM ET

Accepted

Feb 7, 10:11 AM ET

Size

21.6 KB

Accession

0000899243-20-003578

Insider Transaction Report

Form 4
Period: 2020-02-07
Hartzell Amy
VP, Supply Chain and Purchasin
Transactions
  • Disposition to Issuer

    Performance Shares

    2020-02-071,0130 total
    Common Stock (1,013 underlying)
  • Disposition to Issuer

    Performance Shares

    2020-02-071,3960 total
    Common Stock (1,396 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2020-02-073,0590 total
    Exercise: $52.51Exp: 2027-04-03Common Stock (3,059 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2020-02-075,5640 total
    Exercise: $39.28Exp: 2028-04-02Common Stock (5,564 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2020-02-0710,1060 total
    Exercise: $31.03Exp: 2029-04-01Common Stock (10,106 underlying)
  • Disposition to Issuer

    Common Stock, par value $0.001 per share

    2020-02-0711,8430 total
  • Disposition to Issuer

    Performance Shares

    2020-02-076850 total
    Common Stock (685 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2020-02-0711,2720 total
    Exercise: $33.53Exp: 2026-04-13Common Stock (11,272 underlying)
Footnotes (3)
  • [F1]Pursuant to the Agreement and Plan of Merger among the Issuer, Iris Parent LLC ("Parent") and Iris Merger Sub 2019, Inc. dated as of October 20, 2019, the Issuer became a wholly owned subsidiary of Parent upon consummation of the merger (the "Effective Time") on February 7, 2020. At the Effective Time, each share of the Issuer's common stock, par value $0.001 per share ("Common Stock"), (including each restricted share) was automatically converted into the right to receive $32.00 in cash, without interest.
  • [F2]Each performance share represented the right to receive shares of Common Stock, subject to the achievement of certain performance measures. Pursuant to the Merger Agreement, as of the Effective Time, each performance share outstanding and unvested immediately prior to the Effective Time was cancelled and converted into the right to receive an amount in cash equal to (i) the target number of shares of Common Stock subject to such performance share multiplied by (ii) $32.00, plus the amount of any accrued but unpaid dividend equivalents associated with such performance share, less any applicable tax withholding.
  • [F3]Pursuant to the Merger Agreement, each stock option outstanding and unexercised immediately prior to the Effective Time immediately vested (if unvested) and was converted into the right to receive an amount in cash equal to (i) the number of shares of Common Stock subject to such stock option multiplied by (ii) the excess of (x) $32.00 over (y) the exercise price payable in respect of each share of Common Stock subject to such stock option, less any applicable tax withholding; provided, however, that stock options with an exercise price equal to or greater than $32.00 were cancelled without the right to receive any cash payment in consideration thereof.

Issuer

Innophos Holdings, Inc.

CIK 0001364099

Entity typeother

Related Parties

1
  • filerCIK 0001675176

Filing Metadata

Form type
4
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 10:11 AM ET
Size
21.6 KB